Market Access News | pharmaphorum

News

CHMP backs Ipsen drug for childhood brain cancer

Ipsen's Ojemda is on course to become the first targeted medicine in the EU for some children with a form of brain cancer known as low-grade glioma.

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

News

Moderna closes on EU approval for combined flu/COVID jab

Moderna's combined vaccine for both flu and COVID-19 has been recommended for approval in the EU, after being knocked back in the US.

News

Hernexeos box, two pills, and pill bottle

Boehringer gets FDA's second 'national priority' approval

Boehringer Ingelheim's lung cancer drug Hernexeos has become the second medicine approved after an FDA national priority review.

News

US lawmakers take FDA to task over rare diseases record

Lawmakers and patient advocates in the US are concerned that the FDA's regulation of rare disease therapies has been inconsistent and overly cautious.

News

In brief SOTU remarks, Trump asks Congress to "codify" MFN

In a speech at least nominally focused on the economy and affordability, President Trump put surprisingly little emphasis on his drug pricing efforts.

CHMP backs Ipsen drug for childhood brain cancer

NHS "isn't delivering equitable care for rare diseases"

Moderna closes on EU approval for combined flu/COVID jab

Boehringer gets FDA's second 'national priority' approval

US lawmakers take FDA to task over rare diseases record

In brief SOTU remarks, Trump asks Congress to "codify" MFN

AI specialist Chai Discovery raises $400m

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks